Contact
Wilbert S. Aronow, M.D., has edited more than 20 books and is the author or co-author of 1,900+ papers, more than 200 chapters in 100+ books, nearly 1,000 commentaries, 50 Letters to the Editor, 1,200+ abstracts, and is a presenter or co-presenter of more than 1,600 talks at meetings. Dr. Aronow has been a member of almost 200 editorial boards of medical journals. He has been a member of 4 national guidelines committees including being a coauthor of the 2010 AMDA guidelines for heart failure, a co-chair and first author of the 2011 ACC/AHA expert consensus document on hypertension in the elderly, a coauthor of the 2015 AHA/ACC/ASH scientific statement on treatment of hypertension in patients with coronary artery disease, and a coauthor of the 2017 ACC/AHA guidelines for the management of patients with hypertension. He was a co-author of a 2015 position paper from the International Lipid Expert Forum. Dr. Aronow has been a committee member of numerous professional societies and a consultant to many government agencies. He has mentored more than 1,200 physicians and medical students, as well as has 1,600+ papers listed on PubMed during his professional career.
Education
- Fellowship: Cardiology
- Residency: Internal Medicine
- M.D., Harvard Medical School
Areas of Expertise
- Cardiovascular Disease
- Preventive Cardiology
Honors and Awards
- 90 Honors including NYMC Chancellor's Research Award
- 2 NYMC 2021 Excellence in Teaching Dean's Faculty Award
- NYMC library 2024 Award for mentoring residents
Publications
- Thukral J, Moudgil P, Sindhwani N, et. al. "Clonal Cytopenias of Undetermined Significance and Cardiovascular Disease: Inflammatory Mechanisms, Risk Stratification, and Clinical Outcomes." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001267
- Passey S, Erum M, Patel N, et. al. "Safe prescribing of antihypertensive drugs in the elderly and managing the risk of adverse events." Expert opinion on drug safety, (), (2026) . doi: 10.1080/14740338.2026.2653753
- Thukral J, Moudgil P, Rohewal J, et. al. "Immune Checkpoint Inhibitor-Associated Myocarditis: Current Understanding of Clinical Presentation and Management." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001257
- Thukral J, Moudgil P, Ratol HK, et. al. "Poly(ADP-Ribose) Polymerases Inhibition in Cardiovascular Oncology: Protective Mechanisms Versus Clinical Cardiotoxicity." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001255
- Jafri DZ, Beck JM, Kaplan SA, et. al. "Updates in the Treatment of Pediatric Pulmonary Arterial Hypertension." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001239
- Agrawal SP, Dunde A, Maniyar P, et. al. "Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001220
- Mathukumar A, Frishman WH, Aronow WS, et. al. "Gender Disparities in Cardiovascular Health: A Review of Risk Factors, Clinical Presentation, and Associated Outcomes." Cardiology in review, (), (2026) . doi: 10.1097/CRD.0000000000001236
Memberships and Affiliations
- FACC
- FAHA
- FACP
- FCCP
- FASPC
- AGSF
- FGSA
Teaching Responsibilities
- Mentor cardiology fellows
- Mentor medical residents
- Mentor medical students
